I’m already looking forward to next year’s conference and continuing to network and connect with people in the healthcare industry. My biggest take away was the roundtable discussion I participated in. The topic revolved around country selection and feasibility. It was very interesting to me that although some of the talks were on global site selection, a number of participants were interested in learning about process and timing of country selection. It seems to me that even though most clinical trial sponsors (pharma or device companies) are conducting their studies globally, the selection of each country is done by accessibility, location of affiliates offices, etc. There is additional room for improvement, education, and progress to make the best decision about country selection that meets the clinical trial needs.